← All companies
IRWD
Ironwood Pharmaceuticals, Inc.
$4.42
+0.69 +18.50%
Key statistics
from XBRL data in SEC filingsMarket cap
$728M
Revenue (TTM)
$362M
Net income (TTM)
$102M
EPS (TTM)
$0.60
P/E ratio
7.4
Dividend yield
—
Free cash flow
$127M
Cash
$220M
Total assets
$435M
Gross margin
—
52-week range
$0.72 – $5.78
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Shareholder vote results
Jun 18, 2026
8-K
Other events
Jun 15, 2026
8-K/A
Director or officer change
May 21, 2026
8-K
Director or officer change
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release)
May 7, 2026
8-K
Other events
Mar 11, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 25, 2026
8-K
Results of operations (earnings release)
Jan 2, 2026
8-K
Entered a material agreement; Other events
Dec 23, 2025
8-K
Other events
Nov 26, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Director or officer change
Oct 10, 2025
8-K
Other events
Sep 3, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Changed accountants
Jul 10, 2025
8-K
Shareholder vote results
Jun 12, 2025
8-K
Delisting notice or listing-rule failure
Jun 3, 2025
10-Q
Quarter ended 2025-03-31
May 12, 2025
8-K
Results of operations (earnings release)
May 7, 2025
8-K
Results of operations (earnings release)
Apr 25, 2025
8-K
Other events
Apr 14, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Mar 27, 2025
8-K
Results of operations (earnings release)
Feb 27, 2025
8-K
Exit or disposal costs; Director or officer change
Jan 29, 2025
8-K
Director or officer change
Dec 5, 2024
8-K
Director or officer change
Nov 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Sep 30, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Shareholder vote results
Jun 21, 2024
8-K
Director or officer change; Other events
Jun 20, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release)
May 9, 2024